首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 製藥業委外市場
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

製藥業委外市場

Legal aspects of outsourcing in the pharmaceutical industry: A practical guide

出版商 Pharmalicensing Ltd.
出版日期 2006年02月 商品編碼 36176
內容資訊 英文 128 pp including 6 sample contracts
價格
US $ 895 PDF by E-mail (Single User License)


製藥業委外市場 是由出版商Pharmalicensing Ltd.在2006年02月所出版的。 這份英文市場調查報告書包含128 pp including 6 sample contracts 價格從美金895起跳。

簡介

專研製藥、生技、保健領域,素有好評的英國市調公司 Bridgehead International Limited(總公司:英國雷斯塔夏),由法律觀點觀察製藥業的委外狀況後,出版了一本綜合報告書 "Legal aspects of outsourcing in the pharmaceutical industry: A practical guide"

報告書內容包括:製藥業對委外的認知與法律事項、臨床與臨床研究、於生產、物流、銷售等領域的委外合約項目等等,內容綱要摘記如下:

第1章 前言

第2章 委外合約與主要法律事項

  • 合約法
  • 知識財產
  • 雇用問題
  • 生產物責任

第3章 選定與適當評估

  • 前言
  • 提案委託

第4章 準備文書

  • 守密義務合約
  • 同意書
  • 條件概要書
  • 供應商合約書

第5章 委外合約

  • 合約角色與結構
    • 前言
    • 主要合約
    • 服務層級合約
  • 委外合約使用的共通用語
    • 當事人
    • 說明事項
    • 定義
    • 解釋吧
    • 指名
    • 使用期間
    • 守密義務
    • 資料、發明、與權利的所有
    • 公開
    • 財務與商業用語
    • 當事人關係
    • 保證、賠償與保險
    • 期間與與期間屆滿
    • 合約滿足的結論
    • 不可抗力
    • 業務委託與下包
    • 整體合約改訂與免除事項
    • 通知
    • 資料保護
    • 法律、紛爭解決、管轄
    • 第三者權利
    • 不法期間的分離
    • 時程表

第6章 服務層級、期間與文書

  • 前言
  • 服務層級內容與語言
  • 公式與評估指標
  • 服務層級評估

第7章 成功的合約與交涉

  • 前言
  • 伙伴關係建立
  • 交涉與合約內容訂定時的律師借助
  • 透明性
  • 公平性
  • 流通性的建立
  • 持續性支援的提供
  • 原理原則的確立
  • 國際性委外合約交涉
  • 共通的交涉錯誤

第8章 委託生產的關注事項

  • 前言
  • 選定與適當評估
  • 合約書製作
  • 技術轉移
  • 生產方法與供給
  • 訂貨與觀察
  • 銷售價格與期間
  • 零件、產品進貨、拒絕與供給錯誤
  • 委託人義務
  • 服務供應商的義務
  • 執照與知識財產
  • 保證與賠償
  • 期間與期滿
  • 補足
  • 技術(或品質)合約
    • 前言
    • 溝通
    • 品質調查
    • 生產文書
    • 批號與追蹤
    • 不良
    • 訪問、監察、檢查
    • 抽樣與試驗
    • 抱怨與召回
    • 年度產品回顧
    • 變更管理
    • 最終許可

第9章 物流領域的關注事項

  • 合約關注事項
    • 服務
    • 服務供應商的義務
    • 工作人員管理
    • 佔地
    • 所有權
    • 責任
  • 補足

第10章 臨床研究

  • 前言
  • 合約關注事項
    • 指名
    • 服務供應商的一般義務
    • 主要關係者
    • 患者數
    • 藥物研究
    • 報告
    • 問題報告
    • 實地檢查
    • 委託業者
    • 研究義務的結束
    • 排除人士
    • 主要調查期間
    • 委託人義務
    • 收費與支付
    • 變動
    • 合約期滿與其影響
  • 補足

第11章 委託銷售

  • 前言
  • 合約關注事項
    • 服務
    • 委託銷售機構的義務
    • 委託人義務
    • 財產
    • 責任與保障
    • 問題因應
    • 合約期滿與其結論
    • 時程表

第12章 設備管理

  • 前言
  • 合約關注事項
    • 服務
    • 委託業者的義務
    • 經營人員
    • 變更指示
    • 服務確認
    • 佔地
    • 健康與安全、教育、員工
    • 第三者合約
    • 紀錄與檢查

第13章 衝突因應與出口管道

  • 前言
  • 衝突迴避與管理
  • 出口管道

第14章 附錄

目錄

Abstract

Paul Ranson's comprehensive report covers the contractual features of the outsourcing process from start to finish. This report includes information on the legal aspects of outsourcing services at all stages of product development, manufacturing and exploitation, including preclinical and clinical research, manufacture, logistics and sales.

By affording a background to the key legal issues in this field, this provides a manual for individuals new to outsourcing, as well as support for those familiar with the area. More than just an overview, this report is a practical guide to the process--the sections on drafting issues, documentation, negotiation and termination take readers step by step through the legal aspects of the outsourcing process.

The report includes an extensive selection of examples of the various types of outsourcing agreements. In addition there is a glossary of legal terms to assist the non-lawyer and information and specific considerations in different types of outsourcing to support contract development.

Table of Contents

1. Introduction: The extent and nature of outsourcing and the procurement of services

  • 1.1. Screening
    • 1.1.1. Identifying targets and leads
    • 1.1.2. Lead prioritization
    • 1.1.3. Lead identification
  • 1.2. Preclinical development
    • 1.2.1. In vitro/in vivo studies
    • 1.2.2. Chemical manufacturing controls (CMC)/pharmaceutics
    • 1.2.3. Pharmacology/toxicology
  • 1.3. Clinical research
    • 1.3.1. Preparing for clinical studies
    • 1.3.2. Phase I clinical studies
    • 1.3.3. Phase II clinical studies
    • 1.3.4. Phase III clinical studies
    • 1.3.5. Post-marketing trials
    • 1.3.6. Central laboratories
    • 1.3.7. Enrolment
    • 1.3.8. IVRS
  • 1.4. Manufacturing
  • 1.5. Logistics
    • 1.5.1. Finished product inventory
    • 1.5.2. Order processing, allotment and inventory management
    • 1.5.3. Transportation
    • 1.5.4. Import/export
  • 1.6. Sales and marketing
  • 1.7. Information technology, other aspects of facilities management and outsourced services
    • 1.7.1. Information technology
    • 1.7.2. Other outsourced facilities and services

2. Some key legal issues in outsourcing agreements

  • 2.1. Contract law
    • 2.1.1. Origins of contract law
    • 2.1.2. Common and civil law
      • 2.1.2.1. Consideration
      • 2.1.2.2. Privity of contract
      • 2.1.2.3. Good faith
      • 2.1.2.4. Interpreting a contract
    • 2.1.3. EU harmonized contract law
    • 2.1.4. Making the contract
      • 2.1.4.1. Offer and acceptance
      • 2.1.4.2. Completeness and certainty
      • 2.1.4.3. Consideration
      • 2.1.4.4. Intention to create legal relations
    • 2.1.5. Substance of the contract
      • 2.1.5.1. Negotiation statements
      • 2.1.5.2. Promises
      • 2.1.5.3. Implied terms
      • 2.1.5.4. Exclusion clauses
    • 2.1.6. Ending the contract
      • 2.1.6.1. Breach
      • 2.1.6.2. Damages
  • 2.2. Intellectual property
    • 2.2.1. Introduction
    • 2.2.2. Patents
    • 2.2.3. Confidential information
    • 2.2.4. Trade marks
    • 2.2.5. Copyright
    • 2.2.6. Designs
  • 2.3. Employment issues
    • 2.3.1. Introduction
    • 2.3.2. Ambit of the ARD
    • 2.3.3. Effect of the ARD
  • 2.4. Product liability
    • 2.4.1. Introduction
    • 2.4.2. The Directive and negligence
    • 2.4.3. Product
    • 2.4.4. Producer
    • 2.4.5. Defect
    • 2.4.6. Damages
    • 2.4.7. Defenses under the Act

3. Selection and due diligence

  • 3.1. Introduction
  • 3.2. The request for proposals
    • 3.2.1. Introduction
    • 3.2.2. The structure of the RFP
    • 3.2.3. Setting the terms of the RFP
    • 3.2.4. Due diligence
      • 3.2.4.1. Capacity and flexibility
      • 3.2.4.2. Capability
      • 3.2.4.3. Experience
      • 3.2.4.4. Financial stability
      • 3.2.4.5. Quality Control and Assurance Procedures
      • 3.2.4.6. Location
      • 3.2.4.7. Cultural fit
      • 3.2.4.8. Compliance
      • 3.2.4.9. Staff training
      • 3.2.4.10. Existing client loyalty

4. Preliminary documentation

  • 4.1. Confidentiality agreements
    • 4.1.1. The parties
    • 4.1.2. Definitions
    • 4.1.3. Obligations of the recipient
    • 4.1.4. Further rights
    • 4.1.5. Duration
    • 4.1.6. Exclusions
    • 4.1.7. Choice of law
  • 4.2. Letters of intent/recording understandings
    • 4.2.1. Purpose
    • 4.2.2. Drafting issues
    • 4.2.3. The duty to negotiate in good faith
  • 4.3. Term sheets and heads of terms
  • 4.4. Preferred provider agreements

5. The outsourcing agreement: General drafting issues

  • 5.1. The role and structure of the contract
    • 5.1.1. Introduction
    • 5.1.2. Master agreements
    • 5.1.3. Service level agreements
  • 5.2. Common terms in outsourcing agreements
    • 5.2.1. The parties
    • 5.2.2. Recitals
    • 5.2.3. Definitions
      • 5.2.3.1. Affiliates
      • 5.2.3.2. Applicable legislation
      • 5.2.3.3. Authorities/regulatory authorities
      • 5.2.3.4. Confidential information
      • 5.2.3.5. Effective date
      • 5.2.3.6. Improvements/inventions
      • 5.2.3.7. Intellectual property rights (IPRs)
      • 5.2.3.8. Know-how
      • 5.2.3.9. Patents
      • 5.2.3.10. Territory
      • 5.2.3.11. Trade marks
    • 5.2.4. Interpretation
    • 5.2.5. Appointment
    • 5.2.6. Performance terms
    • 5.2.7. Confidentiality
    • 5.2.8. Ownership of data, inventions and rights
    • 5.2.9. Publication
    • 5.2.10. Financial or commercial terms
    • 5.2.11. Relationship of the parties
    • 5.2.12. Warranties, indemnities and insurance
    • 5.2.13. Duration and termination
    • 5.2.14. Consequences of termination
    • 5.2.15. Force majeure
    • 5.2.16. Assignment and sub-contracting
    • 5.2.17. Entire agreement modification and waiver
    • 5.2.18. Notices
    • 5.2.19. Data protection
    • 5.2.20. Governing law, dispute resolution and jurisdiction
    • 5.2.21. Third party rights
    • 5.2.22. Severance of illegal terms
    • 5.2.23. Schedules

6. Service level terms and documents

  • 6.1. Introduction
  • 6.2. Service level content and language
  • 6.3. Specifying formulae and metrics
  • 6.4. Measuring service levels
    • 6.4.1. Which service levels should be measured?
    • 6.4.2. What process should be used to measure achieved performance?
    • 6.4.3. The measurement period
    • 6.4.4. Reports
    • 6.4.5. Performance commitments
    • 6.4.6. Improving service levels
      • 6.4.6.1. Continuing improvement
      • 6.4.6.2. External metrics
    • 6.4.7. Use of service level credits
    • 6.4.8. Service level bonuses
    • 6.4.9. Service levels and termination

7. Successful contract drafting and negotiation

  • 7.1. Introduction
  • 7.2. Building in partnership
  • 7.3. Using lawyers in negotiation and developing the agreement structure
  • 7.4. Openness
  • 7.5. Fairness
  • 7.6. Building in flexibility
  • 7.7 Providing for continuous support
  • 7.8. Establishing disciplines
  • 7.9. Negotiating international outsourcing agreements
  • 7.10. Common negotiating mistakes
    • 7.10.1. Conflict model
    • 7.10.2. Misplaced trust
    • 7.10.3. Fixed positions
    • 7.10.4. Over-commitment
    • 7.10.5. Overconfidence
    • 7.10.6. Ignoring bargaining power

8. Specific considerations in contract manufacture

  • 8.1. Introduction
  • 8.2. Selection and due diligence
  • 8.3. Creating a contract
  • 8.4. Technical transfer
  • 8.5. Manufacturing methods and supply
  • 8.6. Orders and forecasts
  • 8.7. Price and terms of sale
  • 8.8. Acceptance/rejection of compound/product and failure to supply
  • 8.9. Obligations of the client
  • 8.10. Obligations of the service provider
  • 8.11. Licenses and IP
  • 8.12. Warranties and Indemnification
  • 8.13. Term and termination
  • 8.14. Miscellaneous
  • 8.15. Technical (or quality) agreement
    • 8.15.1. Introduction
    • 8.15.2. Communication
    • 8.15.3. Quality investigations
    • 8.15.4. Production documentation
    • 8.15.5. Batch numbering and tracking
    • 8.15.6. Deviations
    • 8.15.7. Visits, audits and inspections
    • 8.15.8. Sampling and testing
    • 8.15.9. Subcontracting
    • 8.15.10. Complaints and recall
    • 8.15.11. Annual product review
    • 8.15.12. Change control
    • 8.15.13. Final approval

9. Specific considerations in logistics

  • 9.1. Specific contract considerations
    • 9.1.1. Services
    • 9.1.2. Service provider's obligations
    • 9.1.3. Management of staff
    • 9.1.4. Premises
    • 9.1.5. Proprietary rights
    • 9.1.6. Liability
  • 9.2. Miscellaneous

10. Clinical research

  • 10.1. Introduction
  • 10.2. Specific contract considerations
    • 10.2.1. Appointment
    • 10.2.2. Service provider's obligations generally
    • 10.2.3. Key individuals
    • 10.2.4. Patient numbers
    • 10.2.5. Study drug
    • 10.2.6. Reports and reporting
    • 10.2.7. Adverse event reporting
    • 10.2.8. Site inspection
    • 10.2.9. Contractors
    • 10.2.10. End of study obligations
    • 10.2.11. Debarred persons
    • 10.2.12. The principal investigator
    • 10.2.13. Client's obligations
    • 10.2.14. Fees and payment
      • 10.2.14.1. Fixed price and fixed adjustable price contracts
      • 10.2.14.2. Unit price agreements
      • 10.2.14.3. Fee for services
      • 10.2.14.4. Outcomes-based
      • 10.2.14.5. Risk-share agreements
    • 10.2.15. Variations
    • 10.2.16. Termination and effects of termination
  • 10.3. Miscellaneous

11. Contract Sales

  • 11.1. Introduction
  • 11.2. Specific contract considerations
    • 11.2.1. Services
    • 11.2.2. Obligations of the contract sales organization
    • 11.2.3. Obligations of the client
    • 11.2.4. Property
    • 11.2.5. Liability and indemnity
    • 11.2.6. Adverse reactions
    • 11.2.7. Termination and consequences of termination
    • 11.2.8. Schedules

12. Facilities Management

  • 12.1. Introduction
  • 12.2. Specific contract considerations
    • 12.2.1. Services
    • 12.2.2. Contractor's obligations
    • 12.2.3. Management staff
    • 12.2.4. Change order
    • 12.2.5. Review of services
    • 12.2.6. Premises
    • 12.2.7. Health and safety, training and employees
    • 12.2.8. Third party contracts
    • 12.2.9. Records and inspection

13. Managing disputes and exit routes

  • 13.1. Introduction
  • 13.2. Avoiding and managing disputes
    • 13.2.1. Flexibility
    • 13.2.2. Documenting decisions
    • 13.2.3. Separating issues
    • 13.2.4. Good faith
  • 13.3. Exit routes
    • 13.3.1. Introduction
    • 13.3.2. Grounds for termination
    • 13.3.3. Action on termination
    • 13.3.4. Service provider cooperation on termination
    • 13.3.5. Giving an incentive for the service provider to provide termination assistance
    • 13.3.6. Building in measures to deal with service provider crisis

14. Appendices

  • 14.1. Master contract manufacture agreement example
  • 14.2. Master contract clinical research agreement example
  • 14.3. Contract sales agreement example
  • 14.4. Multi-purpose services master agreement example
  • 14.5 Contract logistics agreement example
  • 14.6. Facilities management agreement example
  • 14.7. Glossary, abbreviations and resources
  • 14.8. Biography: Paul Ranson
  • 14.9. Acknowledgements
Back to Top